ascendis pharma glp-1 receptor agonist medications Novo inks deal to develop long-acting GLP-1, other metabolic drugs Novo Nordisk, Ascendis Ink $285M
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27




























